Health Diagnostics

Ellie Diagnostics Raises Equity from Avego Healthcare Capital

Ellie and Avego unite to provide innovative diagnostic solutions to veterinarians

Ellie Diagnostics is pleased to announce a new capital partnership with Avego Healthcare Capital. Through this strategic investment, Avego will support Ellie in the expansion of its unique position as the leading independent diagnostic provider for veterinarians in the United States.

“Veterinarians will benefit tremendously from this new strategic partnership,” said Mark DeCourcy, CEO of Ellie Diagnostics. “We are thrilled to leverage this capital partnership to develop innovative new tools to enhance clinical outcomes and improve the diagnostic experience for our U.S. customers. Our new partners at Avego are a perfect fit with the entrepreneurial and innovative spirit that is at the core of both Ellie Diagnostics and the veterinary industry.”

“Avego has been actively seeking to diversify the fund’s human healthcare portfolio, and our investment in Ellie is an exciting first step toward increasing our exposure to the fast-growing veterinary industry,” said Jordan McLean, Vice President at Avego and Director at Ellie. “We are grateful to partner with Mark, a seasoned lab entrepreneur, and look forward to supporting his vision to disrupt a consolidated industry by providing a superior, customer-centric solution for veterinarians.”   

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to

Related posts

Slingshot Biosciences Announces $23 Million in Series A Financing

Business Wire

GRAIL Introduces Galleri, Multi-Cancer Early Detection Blood Test

Business Wire

Carestream Selects HPE GreenLake to Transform Healthcare Platform

Business Wire